These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 12033379)
1. On the transport of lipoplexes through cystic fibrosis sputum. Sanders NN; Van Rompaey E; De Smedt SC; Demeester J Pharm Res; 2002 Apr; 19(4):451-6. PubMed ID: 12033379 [TBL] [Abstract][Full Text] [Related]
2. Impact of PEGylation on the mucolytic activity of recombinant human deoxyribonuclease I in cystic fibrosis sputum. Guichard MJ; Kinoo D; Aubriot AS; Bauwens N; Gougué J; Vermeulen F; Lebecque P; Leal T; Vanbever R Clin Sci (Lond); 2018 Jul; 132(13):1439-1452. PubMed ID: 29871879 [TBL] [Abstract][Full Text] [Related]
3. Mobility and stability of gene complexes in biogels. Sanders NN; De Smedt SC; Demeester J J Control Release; 2003 Feb; 87(1-3):117-29. PubMed ID: 12618028 [TBL] [Abstract][Full Text] [Related]
4. Cystic fibrosis sputum: a barrier to the transport of nanospheres. Sanders NN; De Smedt SC; Van Rompaey E; Simoens P; De Baets F; Demeester J Am J Respir Crit Care Med; 2000 Nov; 162(5):1905-11. PubMed ID: 11069833 [TBL] [Abstract][Full Text] [Related]
5. Structural alterations of gene complexes by cystic fibrosis sputum. Sanders NN; Van Rompaey E; De Smedt SC; Demeester J Am J Respir Crit Care Med; 2001 Aug; 164(3):486-93. PubMed ID: 11500355 [TBL] [Abstract][Full Text] [Related]
6. Effect of chondroitinase ABC on purulent sputum from cystic fibrosis and other patients. Khatri IA; Bhaskar KR; Lamont JT; Sajjan SU; Ho CK; Forstner J Pediatr Res; 2003 Apr; 53(4):619-27. PubMed ID: 12612214 [TBL] [Abstract][Full Text] [Related]
7. Recombinant human DNase (rhDNase) influences phospholipid composition, surface activity, rheology and consecutively clearance indices of cystic fibrosis sputum. Griese M; App EM; Duroux A; Burkert A; Schams A Pulm Pharmacol Ther; 1997; 10(1):21-7. PubMed ID: 9344829 [TBL] [Abstract][Full Text] [Related]
8. Enhanced viscoelasticity of human cystic fibrotic sputum correlates with increasing microheterogeneity in particle transport. Dawson M; Wirtz D; Hanes J J Biol Chem; 2003 Dec; 278(50):50393-401. PubMed ID: 13679362 [TBL] [Abstract][Full Text] [Related]
9. Role of magnesium in the failure of rhDNase therapy in patients with cystic fibrosis. Sanders NN; Franckx H; De Boeck K; Haustraete J; De Smedt SC; Demeester J Thorax; 2006 Nov; 61(11):962-8. PubMed ID: 17071834 [TBL] [Abstract][Full Text] [Related]
10. Effect of recombinant human DNase on alpha1-proteinase inhibitor function: an experimental approach to the combined clinical use of rhDNase and alpha1-PI in CF patients. Hansen G; Hoffjan S; Mosler K; Schuster A Lung; 2001; 179(3):185-94. PubMed ID: 11891608 [TBL] [Abstract][Full Text] [Related]
11. Apparent Yield Stress of Sputum as a Relevant Biomarker in Cystic Fibrosis. Ghanem R; Roquefort P; Ramel S; Laurent V; Haute T; Le Gall T; Aubry T; Montier T Cells; 2021 Nov; 10(11):. PubMed ID: 34831330 [TBL] [Abstract][Full Text] [Related]
12. Actin limits enhancement of nanoparticle diffusion through cystic fibrosis sputum by mucolytics. Broughton-Head VJ; Smith JR; Shur J; Shute JK Pulm Pharmacol Ther; 2007; 20(6):708-17. PubMed ID: 17055310 [TBL] [Abstract][Full Text] [Related]
13. Polysulfated Hyaluronan GlycoMira-1111 Inhibits Elastase and Improves Rheology in Cystic Fibrosis Sputum. Kummarapurugu AB; Zheng S; Pulsipher A; Savage JR; Ma J; Rubin BK; Kennedy TP; Voynow JA Am J Respir Cell Mol Biol; 2021 Feb; 64(2):260-267. PubMed ID: 33264072 [TBL] [Abstract][Full Text] [Related]
14. The effect of mucolytic agents on gene transfer across a CF sputum barrier in vitro. Stern M; Caplen NJ; Browning JE; Griesenbach U; Sorgi F; Huang L; Gruenert DC; Marriot C; Crystal RG; Geddes DM; Alton EW Gene Ther; 1998 Jan; 5(1):91-8. PubMed ID: 9536269 [TBL] [Abstract][Full Text] [Related]
15. Comparison of physicochemical properties of purified mucus glycoproteins isolated from respiratory secretions of cystic fibrosis and asthmatic patients. Chace KV; Flux M; Sachdev GP Biochemistry; 1985 Dec; 24(25):7334-41. PubMed ID: 3002452 [TBL] [Abstract][Full Text] [Related]
16. Rheology of cystic fibrosis sputum after in vitro treatment with hypertonic saline alone and in combination with recombinant human deoxyribonuclease I. King M; Dasgupta B; Tomkiewicz RP; Brown NE Am J Respir Crit Care Med; 1997 Jul; 156(1):173-7. PubMed ID: 9230743 [TBL] [Abstract][Full Text] [Related]
17. N-acetylcysteine enhances cystic fibrosis sputum penetration and airway gene transfer by highly compacted DNA nanoparticles. Suk JS; Boylan NJ; Trehan K; Tang BC; Schneider CS; Lin JM; Boyle MP; Zeitlin PL; Lai SK; Cooper MJ; Hanes J Mol Ther; 2011 Nov; 19(11):1981-9. PubMed ID: 21829177 [TBL] [Abstract][Full Text] [Related]
18. Improved activity of an actin-resistant DNase I variant on the cystic fibrosis airway secretions. Zahm JM; Debordeaux C; Maurer C; Hubert D; Dusser D; Bonnet N; Lazarus RA; Puchelle E Am J Respir Crit Care Med; 2001 Apr; 163(5):1153-7. PubMed ID: 11316652 [TBL] [Abstract][Full Text] [Related]
19. Anionic poly(amino acid)s dissolve F-actin and DNA bundles, enhance DNase activity, and reduce the viscosity of cystic fibrosis sputum. Tang JX; Wen Q; Bennett A; Kim B; Sheils CA; Bucki R; Janmey PA Am J Physiol Lung Cell Mol Physiol; 2005 Oct; 289(4):L599-605. PubMed ID: 15964901 [TBL] [Abstract][Full Text] [Related]
20. DNA concentration and length in sputum of patients with cystic fibrosis during inhalation with recombinant human DNase. Brandt T; Breitenstein S; von der Hardt H; Tümmler B Thorax; 1995 Aug; 50(8):880-2. PubMed ID: 7570441 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]